Your browser doesn't support javascript.
loading
Efficacy and safety of omalizumab in Chinese patients with anti-histamine refractory chronic spontaneous urticaria.
Yuan, Weiru; Hu, Shuling; Li, Min; Yang, Lijia; Liu, Lingling; Zheng, Min; Guo, Zaipei; Song, Zhiqiang; Zhang, Chunlei; Diao, Qingchun; Xu, Jinhua; Richard, Alexia; Patwardhan, Moreshwar; Lyu, Tianmeng; Uddin, Alkaz; Fogel, Robert; Ligueros-Saylan, Monica; Zheng, Jie.
Affiliation
  • Yuan W; Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Hu S; China Novartis Institutes for BioMedical Research Co., Ltd., Shanghai, China.
  • Li M; Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Yang L; Wuxi No.2 People's Hospital, Wuxi, China.
  • Liu L; Peking University First Hospital, Beijing, China.
  • Zheng M; The Second Affiliated hospital of Zhejiang University School of Medicine, Zhejiang, China.
  • Guo Z; West China Hospital, Sichuan University, Chengdu, China.
  • Song Z; Department of Dermatology, The First Affiliated Hospital of Army Military Medical University, Chongqing, China.
  • Zhang C; Department of Dermatology, Peking University Third Hospital, Beijing, China.
  • Diao Q; Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.
  • Xu J; Huashan Hospital, Fudan University, Shanghai, China.
  • Richard A; Novartis Pharma AG, Basel, Switzerland.
  • Patwardhan M; Novartis Healthcare Pvt. Ltd., Hyderabad, India.
  • Lyu T; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Uddin A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Fogel R; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Ligueros-Saylan M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Zheng J; Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Dermatol Ther ; 35(4): e15303, 2022 04.
Article in En | MEDLINE | ID: mdl-34984792

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Anti-Allergic Agents / Chronic Urticaria Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Humans Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Anti-Allergic Agents / Chronic Urticaria Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Humans Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2022 Document type: Article Affiliation country: